The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
Either FOMO or RNS logged.
Bit of a big wave just hit.
US trades from 2pm will make today even more interesting. An RNS to accompany could blow the doors off.
SP picking up the pace, buys coming in strong.
Flipping nightmare. Is there any scenario we will get money back or are shares now cancelled for good?
The SP should fall till EOD tomorrow in anticipation of new ISA season and FOMO on Thursday. I would then expect decent rises Thursday afternoon and next week.
It's the RNS before the Science day I'm interested in. I don't expect any new update at the Science day. So perhaps RNS week of Feb 20th.
MHRA aren't involved in study design or approval for it, that's the clinical trial outfit sponsored by Avacta. MHRA will assess the study design and outcomes at stage of drug approval. Until then Avacta will focus on being able to present all the necessary data required for some submission of drug approval. Time to get this data is dependant upon phase successes then we enter approval timeline. If there is clear patient benefit but not costing a fortune per dose its easier to get approval. Every drug has reported side effects and these are assessed against patient benefit.
I used to work for the MHRA. Drug safety assessments are long, due to the backlog of requests, and thorough. If though in the case of a drug that has a high positive cost benefit ratio like the covid vaccine, a drug can be prioritised for early safety assessment. There needs to be tangible evidence of high efficacy for prioritisation. Fingers crossed.
They were only supposed to blow the bloody doors off!
Keep pumping guys.
Might not be Lombard. could be Causeway.
If you check the opening price at it equates to about £1.62 so that aligns but closing price there shouldn't mean we open with the same but it's a good sign. It would be madness to open down when the US are 45% up vs our 12%.
That's exactly what Zak said. I don't believe the breakout crap though. SP should rise over coming days but equally it could crash. AIM!
Avacta has burnt me a few times, tbh nothing surprises me anymore, 100p wouldn't! The only difference this time is there is an actual tangible positive update. Let's hope SP will do what it should and have another blue day tomorrow.
I think SP in the long run has the potential to do very well plus could be takeover tumours. But if no new news is forthcoming at the science day then SP could stagnate. Wouldn't surprise me in the least if this went sub 140p tomorrow. I hope not as I'm a LTH, but won't sell.
Potential 3 billion valuation. 420 million Mcap now.
https://ukinvestormagazine.co.uk/avacta-shares-are-now-on-the-verge-of-ftse-aim-greatness/
Well getting regulatory approval is a massive milestone, and then getting the product to market. That is all preceded by clinical trial sign off. Takes years. So more to come.
More news needed and yet to come. Its still the beginning of a journey.